Edward M. Liddy's most recent trade in Abbvie Inc was a trade of 177 Stock Equivalent Units done . Disclosure was reported to the exchange on March 31, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AbbVie | Edward M. Liddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 177 | 28,474 | - | - | Stock Equivalent Units | |
| AbbVie | Edward M. Liddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 266 | 27,506 | - | - | Stock Equivalent Units | |
| AbbVie | Edward M. Liddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 284 | 26,944 | - | - | Stock Equivalent Units | |
| AbbVie | Edward M. Liddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,681 | 26,683 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| AbbVie | Edward M. Liddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 311 | 28,094 | - | - | Stock Equivalent Units | |
| AbbVie | Edward M. Liddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 385 | 26,908 | - | - | Stock Equivalent Units |